Windtree Therapeutics Inc [NASDAQ: WINT] gained 13.33% on the last trading session, reaching $1.19 price per share at the time.
Windtree Therapeutics Inc represents 3.56 million in outstanding shares, while the company has a total market value of $13.77 million with the latest information. WINT stock price has been found in the range of $1.09 to $1.35.
If compared to the average trading volume of 9.78M shares, WINT reached a trading volume of 19166166 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Windtree Therapeutics Inc [WINT]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for WINT shares is $4.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on WINT stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Ladenburg Thalmann have made an estimate for Windtree Therapeutics Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 26, 2020.
The Price to Book ratio for the last quarter was 0.41, with the Price to Cash per share for the same quarter was set at 0.10.
Trading performance analysis for WINT stock
Windtree Therapeutics Inc [WINT] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 63.01. With this latest performance, WINT shares gained by 99.33% in over the last four-week period, additionally sinking by -90.21% over the last 6 months – not to mention a drop of -93.19% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for WINT stock in for the last two-week period is set at 70.55, with the RSI for the last a single of trading hit 0.2666, and the three-weeks RSI is set at 0.2041 for Windtree Therapeutics Inc [WINT]. The present Moving Average for the last 50 days of trading for this stock 0.7237, while it was recorded at 0.9517 for the last single week of trading, and 12.9283 for the last 200 days.
Windtree Therapeutics Inc (WINT) Capital Structure & Debt Analysis
According to recent financial data for Windtree Therapeutics Inc. ( WINT), the Return on Equity (ROE) stands at -120.01%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -56.45%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Windtree Therapeutics Inc’s Return on Invested Capital (ROIC) is -175.14%, showcasing its effectiveness in deploying capital for earnings.
Windtree Therapeutics Inc (WINT) Efficiency & Liquidity Metrics
Based on Windtree Therapeutics Inc’s (WINT) latest financial statements, the Debt-to-Equity Ratio is 0.15%, indicating its reliance on debt financing relative to shareholder equity.
Windtree Therapeutics Inc (WINT) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Windtree Therapeutics Inc. (WINT) effectively leverages its workforce, generating an average of -$1482142.86 per employee. The company’s liquidity position is robust, with a Current Ratio of 0.25% and a Quick Ratio of 0.25%, indicating strong ability to cover short-term liabilities.
An analysis of Institutional ownership at Windtree Therapeutics Inc [WINT]
There are presently around $1.39%, or 1.39%% of WINT stock, in the hands of institutional investors.